Camrelizumab Combined With Apatinib Mesylate Tablets and Nab-paclitaxel in the Second-line Treatment of Advanced Gastric Cancer
Condition: Locally Advanced or Metastatic Gastric Adenocarcinoma Interventions: Drug: Camrelizumab; Drug: Apatinib Mesylate; Drug: nab-paclitaxel Sponsor: The First Affiliated Hospital of Xiamen University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Gastric (Stomach) Cancer | Gastroenterology | Hospitals | Research